These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37865988)

  • 41. Cannabinoids and cancer pain: A new hope or a false dawn?
    Brown MRD; Farquhar-Smith WP
    Eur J Intern Med; 2018 Mar; 49():30-36. PubMed ID: 29482740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabinoids as gastrointestinal anti-inflammatory drugs.
    Fabisiak A; Fichna J
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 28239924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis.
    Navarrete C; Garcia-Martin A; DeMesa J; Muñoz E
    Curr Hypertens Rep; 2020 Oct; 22(12):98. PubMed ID: 33089434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling.
    Storozhuk MV; Zholos AV
    Curr Neuropharmacol; 2018 Jan; 16(2):137-150. PubMed ID: 28440188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
    Aly E; Masocha W
    IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes.
    Modaresi F; Talachian K
    Pharmaceut Med; 2022 Dec; 36(6):387-400. PubMed ID: 36357543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis.
    Khan H; Ghori FK; Ghani U; Javed A; Zahid S
    Mol Biol Rep; 2022 Jun; 49(6):5117-5131. PubMed ID: 35182322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabinoids as anticancer drugs: current status of preclinical research.
    Hinz B; Ramer R
    Br J Cancer; 2022 Jul; 127(1):1-13. PubMed ID: 35277658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders.
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Hum Reprod Update; 2020 Jun; 26(4):586-602. PubMed ID: 32347309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endocannabinoid system dysfunction in mood and related disorders.
    Ashton CH; Moore PB
    Acta Psychiatr Scand; 2011 Oct; 124(4):250-61. PubMed ID: 21916860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review).
    Bifulco M; Laezza C; Gazzerro P; Pentimalli F
    Oncol Rep; 2007 Apr; 17(4):813-6. PubMed ID: 17342320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex differences and the endocannabinoid system in pain.
    Blanton HL; Barnes RC; McHann MC; Bilbrey JA; Wilkerson JL; Guindon J
    Pharmacol Biochem Behav; 2021 Mar; 202():173107. PubMed ID: 33444598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Endocannabinoid System: A Target for Cancer Treatment.
    Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endocannabinoid system: Role in depression, reward and pain control (Review).
    Huang WJ; Chen WW; Zhang X
    Mol Med Rep; 2016 Oct; 14(4):2899-903. PubMed ID: 27484193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anxiety Modulation by Cannabinoids-The Role of Stress Responses and Coping.
    Haller J
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases.
    Ramer R; Hinz B
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. From cannabis to the endocannabinoid system: refocussing attention on potential clinical benefits.
    Youssef FF; Irving AJ
    West Indian Med J; 2012 Jun; 61(3):264-70. PubMed ID: 23155985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
    Vemuri VK; Janero DR; Makriyannis A
    Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.